BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Merck
Novartis
McKinsey
Medtronic
Moodys
Boehringer Ingelheim
Citi
Dow
Chinese Patent Office
Queensland Health

Generated: January 24, 2018

DrugPatentWatch Database Preview

Fluphenazine hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic sources for fluphenazine hydrochloride and what is the scope of fluphenazine hydrochloride patent protection?

Fluphenazine hydrochloride
is the generic ingredient in three branded drugs marketed by Ani Pharms Inc, Pharm Assoc, Schering, Apothecon, Fresenius Kabi Usa, Lannett, Mylan, Sandoz, and Watson Labs, and is included in eighteen NDAs. Additional information is available in the individual branded drug profile pages.

There are eighteen drug master file entries for fluphenazine hydrochloride. Twelve suppliers are listed for this compound.
Pharmacology for fluphenazine hydrochloride
Ingredient-typePhenothiazines
Drug ClassPhenothiazine

US Patents and Regulatory Information for fluphenazine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs FLUPHENAZINE HYDROCHLORIDE fluphenazine hydrochloride TABLET;ORAL 088527-001 Dec 18, 1987 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sandoz FLUPHENAZINE HYDROCHLORIDE fluphenazine hydrochloride TABLET;ORAL 089586-004 Oct 16, 1987 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Lannett FLUPHENAZINE HYDROCHLORIDE fluphenazine hydrochloride TABLET;ORAL 089743-002 Aug 25, 1988 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Mylan FLUPHENAZINE HYDROCHLORIDE fluphenazine hydrochloride TABLET;ORAL 089804-004 Aug 12, 1988 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Apothecon PROLIXIN fluphenazine hydrochloride TABLET;ORAL 011751-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Watson Labs FLUPHENAZINE HYDROCHLORIDE fluphenazine hydrochloride TABLET;ORAL 088555-001 Dec 18, 1987 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Schering PERMITIL fluphenazine hydrochloride TABLET;ORAL 012034-006 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Schering PERMITIL fluphenazine hydrochloride CONCENTRATE;ORAL 016008-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Schering PERMITIL fluphenazine hydrochloride TABLET, EXTENDED RELEASE;ORAL 012419-004 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Lannett FLUPHENAZINE HYDROCHLORIDE fluphenazine hydrochloride TABLET;ORAL 089743-001 Aug 25, 1988 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

McKesson
Daiichi Sankyo
Medtronic
Chinese Patent Office
Queensland Health
Covington
QuintilesIMS
Farmers Insurance
Novartis

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot